{"id":10024,"date":"2023-06-26T15:09:00","date_gmt":"2023-06-26T13:09:00","guid":{"rendered":"https:\/\/aphp-mobile-web.fr\/applis\/recos-thromboses\/?p=10024"},"modified":"2026-05-19T12:22:31","modified_gmt":"2026-05-19T10:22:31","slug":"page-7","status":"publish","type":"post","link":"https:\/\/aphp-mobile-web.fr\/applis\/recos-thromboses\/page-7\/","title":{"rendered":"7 – Bibliographie"},"content":{"rendered":"\n\n\n\n
\"\"<\/div>\n
\n\nANSM. Questions\/R\u00e9ponses.Anticoagulants et nouveaux anticoagulants. 2013 [consult\u00e9 le 12 f\u00e9vrier 2016]\n\nDocument PDF\n<\/a>\n\nANSM. Vous et votre traitement anticoagulant par AVK (antivitamine K). 2013 [consult\u00e9 le 12 f\u00e9vrier 2016]\n\nDocument PDF\n<\/a>\n\nESC recommandations 2010 : European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U,\nSavelieva I, Ernst S et al. ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2010 ; 31 (19) : 2369-429\n\nESC recommandations 2011 : Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H et al (ESC Committee for Practice Guidelines). ESC Guidelines for the\nmanagement of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2011 ; 32 (23) : 2999\u20133054.\n\nESC recommandations 2012 : Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al; ESC Committee for Practice Guidelines (CPG). 2012\nfocused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2012 ; 33 (21) : 2719-47\n\nFNCLC (F\u00e9d\u00e9ration Nationale des Centre de Lutte contre le Cancer) Standards, Options : Recommandations 2008 : Mahe I, Elalamy I, Farge-Bancel D, Mismetti\nP, Scrobohaci ML, Hocini H et al. Traitement curatif de la maladie thromboembolique veineuse, pr\u00e9vention et traitement des thromboses veineuses sur\ncath\u00e9ter chez les patients atteints de cancer. J Mal Vasc 2008; 33, (3) : 140-54.\n\nGage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, Radford MJ. Clinical classification schemes for predicting hemorrhage: results from the\nNational Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006 ; 151 (3) : 713-9.\n\nGEHT et SFMV recommandations 2009 : Pernod G, Biron-Andreani C, Emmanuel Morange P, Boehlen F, Constans J, Couturaud F et al. Recommandations pour la\nrecherche de facteurs biologiques de risque dans le cadre de la maladie thromboembolique veineuse : applications cliniques. Sang Thrombose Vaisseaux 2009 ;\n21 (n\u00b0 special) : 5-11.\n\nGIHP et GEHT 2011 : Si\u00e9 P, Samama C-M, Godier A, Rosencher N, Steib A, Llau JV, et al. Chirurgies et actes invasifs chez les patients traits au long cours\npar un anticoagulant anti-IIa ou anti-Xa direct. Propositions du Groupe d\u2019Int\u00e9r\u00eat en H\u00e9mostase P\u00e9riop\u00e9ratoire (GIHP) et du Groupe d\u2019Etudes sur l\u2019H\u00e9mostase\net la Thrombose (GEHT). Ann Fr Anesth Reanim. 2011 ; 30 : 645\u201350\n\nGIHP 2013 : Pernod G, Albaladejo P, Godier A, Samama C-M, Susen S, Gruel Y, et al. Prise en charge des complications h\u00e9morragiques graves et de la\nchirurgie en urgence chez les patients recevant un anticoagulant oral anti-IIa ou anti-Xa direct. Propositions du Groupe d'int\u00e9r\u00eat en H\u00e9mostase\nP\u00e9riop\u00e9ratoire (GIHP) - mars 2013. Ann Fr Anesth Reanim. 2013 ; 32 : 691\u2013700\n\nGIHP 2015 : Gestion des Anticoagulants Oraux Directs pour la chirurgie et les actes invasifs programm\u00e9s : propositions r\u00e9actualis\u00e9es du Groupe d'Int\u00e9r\u00eat en\nH\u00e9mostase P\u00e9riop\u00e9ratoire (GIHP)--\u2010Septembre 2015 [consult\u00e9 le 12 f\u00e9vrier 2016]\n\nDocument PDF\n<\/a>\n\nGouin-Thibault I, Levy C, Pautas E, Cambus JP, Drouet L, Mah\u00e9 I, Bal Dit Sollier C, Horellou MH, Golmard JL, Siguret V. Improving anticoagulation control\nin hospitalized elderly patients on warfarin. J Am Geriatr Soc. 2010 ; 58(2) : 242-7.www.has-sant\u00e9.fr derni\u00e8re consultation 14\/08\/2014.\n\nHAS recommandations 2008 : prise en charge des surdosages en antivitamines K, des situations \u00e0 risque h\u00e9morragique et des accidents h\u00e9morragiques chez les\npatients trait\u00e9s par antivitamines K en ville et en milieu hospitalier.\n\nPollack CV, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, et al. Idarucizumab for Dabigatran Reversal. N Eng J Med. 2015 ; 373 : 511\u201320.\n\nSFAR RPC 2004 : Samama C-M, Albaladejob P, Laversinc S, Marretd E. Pr\u00e9vention de la maladie thromboembolique veineuse p\u00e9riop\u00e9ratoire et obst\u00e9tricale\nRecommandations pour la pratique clinique. Texte court 2005. Ann Fr Anesth Reanim. 2005 ; 24 : 952\u201376.\n\nSFAR RPC 2001 : Samama C-M, Gafsou B, Jeandel T, Laporte S, Steib A, Marret E, et al. Pr\u00e9vention de la maladie thromboembolique veineuse postop\u00e9ratoire.\nActualisation 2011. Texte court. Ann Fr Anesth Reanim. 2011 ; 30 : 947\u201351.\n\nSiguret V, Gouin I, Debray M, Perret-Guillaume C, Boddaert J, Mah\u00e9 I et al. Initiation of warfarin therapy in elderly medical inpatients: a safe and\naccurate regimen. Am J Med. 2005 ; 118(2) : 137-42.\n\nWells PS, Anderson DR, Bormanis J, et al. Value of assessment of pretest probability of deep vein thrombosis in clinical management. Lancet 1997 ; 350 :\n1795-8.\n\n<\/div>","protected":false},"excerpt":{"rendered":"

ANSM. Questions\/R\u00e9ponses.Anticoagulants et nouveaux anticoagulants. 2013 [consult\u00e9 le 12 f\u00e9vrier 2016] Document PDF ANSM. Vous et votre traitement anticoagulant par AVK (antivitamine K). 2013 [consult\u00e9 le 12 f\u00e9vrier 2016] Document PDF ESC recommandations 2010 : European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst … Continuer la lecture de 7 – Bibliographie<\/span><\/a><\/p>\n","protected":false},"author":95,"featured_media":9986,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10024","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classe"],"acf":[],"_links":{"self":[{"href":"https:\/\/aphp-mobile-web.fr\/applis\/recos-thromboses\/wp-json\/wp\/v2\/posts\/10024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aphp-mobile-web.fr\/applis\/recos-thromboses\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aphp-mobile-web.fr\/applis\/recos-thromboses\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aphp-mobile-web.fr\/applis\/recos-thromboses\/wp-json\/wp\/v2\/users\/95"}],"replies":[{"embeddable":true,"href":"https:\/\/aphp-mobile-web.fr\/applis\/recos-thromboses\/wp-json\/wp\/v2\/comments?post=10024"}],"version-history":[{"count":2,"href":"https:\/\/aphp-mobile-web.fr\/applis\/recos-thromboses\/wp-json\/wp\/v2\/posts\/10024\/revisions"}],"predecessor-version":[{"id":10078,"href":"https:\/\/aphp-mobile-web.fr\/applis\/recos-thromboses\/wp-json\/wp\/v2\/posts\/10024\/revisions\/10078"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aphp-mobile-web.fr\/applis\/recos-thromboses\/wp-json\/wp\/v2\/media\/9986"}],"wp:attachment":[{"href":"https:\/\/aphp-mobile-web.fr\/applis\/recos-thromboses\/wp-json\/wp\/v2\/media?parent=10024"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aphp-mobile-web.fr\/applis\/recos-thromboses\/wp-json\/wp\/v2\/categories?post=10024"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aphp-mobile-web.fr\/applis\/recos-thromboses\/wp-json\/wp\/v2\/tags?post=10024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}